Key result
Substance P treatment significantly increased the expression of cardiac stem/pluripotency-associated genes, including alpha-SMA, GATA4, TBX5, and Klf4, in the right atrium of diabetic rats.
Why the study?
Although Substance P/neurokinin-1 receptor expression is impaired in the right atrium of diabetic patients, the underlying molecular mechanism remains unclear.
Substance P/NK1R signaling modulates the expression of cardiac stem cell-related genes and core transcription factors in the right atrium of diabetic rats, suggesting a mechanism for diabetic atrial remodeling.
SP-NK1R agonism merits mechanistic study in diabetic models; leaves open human atrial effects and clinical translation.
Substance P (SP) is a cardioprotective neuropeptide that interacts with the G protein-coupled neurokinin-1 receptor (NK1R). Although the expression of SP/NK1R in the right atrium (RA) of diabetic patients is known to be significantly impaired, the molecular mechanism remains unclear. LETO and OLETF rats were randomly divided into 3 groups: saline, SP injection (5 nmole/kg), and SP+RP injection (1 mg/kg RP67580, a selective non-peptide tachykinin NK1R antagonist). After 3 weeks, the left atrium (LA), RA, and left ventricle (LV) of the rats were collected. Cardiac stem/pluripotency-associated genes in the diabetic atria of each group were comprehensively examined using qRT-PCR analysis. qRT-PCR analysis demonstrated that only the RA of SP-treated OLETF rats exhibited significantly higher levels of alpha-SMA, GATA4, TBX5, and Klf4 in the mRNA, compared to the control. RP prevented the expression of NK1R and four SP-associated genes in the RA of SP-treated OLETF rats. In conclusion, our findings provide novel mechanistic insights into the role of NK1R in diabetic atria.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2021) studied Diabetes mellitus (diabetic atria) (n=20). Substance P vs. Saline or Substance P + RP67580 was evaluated on Expression of alpha-SMA, GATA4, TBX5, and Klf4 mRNA in the right atrium. Substance P treatment significantly increased the expression of cardiac stem/pluripotency-associated genes, including alpha-SMA, GATA4, TBX5, and Klf4, in the right atrium of diabetic rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: